Acta Oncologica

短名Acta. Oncol.
Journal Impact2.58
国际分区ONCOLOGY(Q3)
期刊索引SCI Q3中科院 3 区
ISSN0284-186X, 1651-226X
h-index119
国内分区医学(3区)医学肿瘤学(4区)

ACTA ONCOLOGICA 是一本面向临床肿瘤学家的期刊,接受所有临床癌症研究领域的文章。也欢迎有关肿瘤病理学、实验肿瘤学、放射生物学、癌症流行病学和医学放射物理学的文章,特别是如果它们具有临床目标或兴趣。也欢迎有关癌症护理和癌症心理或社会方面的科学文章。大量材料可作为增刊出版,适用特殊条件。

期刊主页投稿网址
涉及主题医学内科学生物遗传学外科癌症病理放射科肿瘤科放射治疗化学物理数学免疫学生物化学化疗
出版信息出版商: Medical Journals Sweden AB出版周期: Bimonthly期刊类型: journal
基本数据创刊年份: 1968原创研究文献占比91.53%自引率:7.40%Gold OA占比: 34.24%
平均审稿周期 网友分享经验:平均3月
平均录用比例网友分享经验:约50%

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers

2024-9-10

Changes in perfusion and permeability in glioblastoma model induced by the anti-angiogenic agents cediranib and thalidomide

2024-8-14

Radiation-associated cutaneous mastocytosis: a case report and review of the literature

2024-8-14

Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab

2024-8-11

18F-FDG-PET/CT in breast cancer imaging: Restaging and Implications for treatment decisions in a clinical practice setting

2024-8-11

Multi-disciplinary team meetings for lung cancer in Norway and Denmark: results from national surveys and observations with MDT-MODe

2024-8-11

Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study

2024-8-8

Electron beam radiotherapy for the management of squamous cell carcinoma of the anal margin

2024-8-8

Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy

2024-8-5

Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study

2024-8-4

Real-life experience with sorafenib for advanced and refractory desmoid-type fibromatosis

2024-8-4

Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma

2024-8-4

Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries

2024-8-4

A comparative analysis of fear of cancer recurrence in patients with small renal masses: Active surveillance versus cryoablation

2024-7-22

Psychometric properties of the Swedish version of the Parenting Concerns Questionnaire in parents with cancer

2024-7-22

The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy – the TABANETOC trial: study protocol for a randomized clinical multicenter trial

2024-7-22

Germline variants in patients diagnosed with pediatric soft tissue sarcoma

2024-7-22

The National Swedish Lymphoma Register – a systematic validation of data quality

2024-7-10

Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland

2024-7-5

177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer

2024-7-5

Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017

2024-7-5

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up

2024-7-5

Treatment-related mortality in childhood cancer patients – who, when and how much

2024-7-1

Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes – a cross-sectional study

2024-6-30

Lung cancer: a nationwide analysis of sex and age incidence trends from 1980 to 2022

2024-6-30

The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer

2024-6-30

Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer

2024-6-23

Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study

2024-6-23

The time has come for national clinical practice guidelines for managing late effects after cancer and cancer treatment

2024-6-23

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare

2024-6-23

Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial

2024-6-23

Comparison of the use of a clinically implemented deep learning segmentation model with the simulated study setting for breast cancer patients receiving radiotherapy

2024-6-20

Parenting under pressure: a cross-sectional questionnaire study of psychological distress, parenting concerns, self-efficacy, and emotion regulation in parents with cancer

2024-6-20

Commentary to ‘Incidence of vestibular schwannoma in Finland, 1990–2017’ Pediatric vestibular schwannomas: an overlooked epidemiological aspect?

2024-6-20

Robust optimization of the Gross Tumor Volume compared to conventional Planning Target Volume-based planning in photon Stereotactic Body Radiation Therapy of lung tumors

2024-6-20

A study of microRNAs as new prognostic biomarkers in anal cancer patients

2024-6-20

Clinical trials in older patients with cancer – typical challenges, possible solutions, and a paradigm of study design in breast cancer

2024-6-17

Health-Related Quality of Life in Danish Cancer Survivors Referred to a Late Effects Clinic: A Prospective Cohort Study

2024-6-16

Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences

2024-6-16

Relative risk of second malignant neoplasms highest among young adult cancer patients – a population-based registry study in Finland

2024-6-8

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST

2024-5-28

Immune cell populations in the tumour environment following calcium electropora­tion for cutaneous metastasis: a histopathological study

2024-5-28

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe

2024-5-23

The Tumor Immune Microenvironment in Breast Cancer Progression

2024-5-23

Desmoplastic non-infantile ganglioglioma mimicking diffuse leptomeningeal glioneuronal tumor: precision diagnostics and therapeutic implications

2024-5-23

Agent orange exposure and prostate cancer risk in the million veteran program

2024-5-23

The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP)

2024-5-23

IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results

2024-5-23

A national precision cancer medicine implementation initiative for Finland

2024-5-23

Treatment of vulvar cancer recurrence with electrochemotherapy: a case-control study

2024-5-21

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司